Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Post by Stocktreeon Sep 14, 2023 2:04pm
156 Views
Post# 35636584

EBITDA BS

EBITDA BS
MM, an EDT shill, like others on this BB, like to sell the EBITDA BS, along with other dubious claims and projections, while brushing away the history of the company, it's lies, false promises,past and current management problems and the hold that EDT's backers have on it and its SP. Those backers will have first hand knowledge of any positive news before the open market, and if that news is ever to be an upcoming FDA approval related to an interesting future cash flow, will just swallow the company at a very very very cheap price before you have the time to say "I think something big is coming", and you will never hear of M$M, his Accuntpice and their chearleaders ever again.

This is what Warren Buffett had to say about EBITDA:

“When CEOs tout EBITDA as a valuation guide, wire them up for a polygraph test...
…references to EBITDA make us shudder – does management think the tooth fairy pays for capital expenditures? We’re very suspicious of accounting methodology that is vague or unclear, since too often that means management wishes to hide something...
...… full reporting means giving you the information that we would wish you give us if our positions were reversed. What Charlie and I would want under that circumstance would be all the important facts about current operations as well as the CEO’s frank view of the long-term economic characteristics of the business.


<< Previous
Bullboard Posts
Next >>